Drug Profile
BNP 158
Latest Information Update: 21 May 2001
Price :
$50
*
At a glance
- Originator IVAX Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 21 May 2001 No-Development-Reported for Erectile dysfunction in USA (Topical)
- 13 Jul 1998 New profile
- 13 Jul 1998 Phase-I clinical trials for Erectile dysfunction in USA (Topical)